RRx-001

• CAT Number: I005506
• CAS Number: 925206-65-1
• Molecular Formula: C5H6BrN3O5
• Molecular Weight: 268.02
• Purity: ≥95%
• Synonyms: RRx001;RRx 001
• Target: Anti-infection
• Solubility: 10 mM in DMSO
• Storage: Store at -20C
• Related CAS: 885267-00-5 40299-87-4 563-70-2 30432-16-7
• IC50: 0.14 ± 0.04 ug/ml
• IUPAC Name: 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone
• InChI: InChI=1S/C5H6BrN3O5/c6-1-4(10)7-2-5(3-7,8(11)12)9(13)14/h1-3H2
• InChIKey: JODKFOVZURLVTG-UHFFFAOYSA-N
• SMILES: C1C(CN1C(=O)CBr)([N+](=O)[O-])[N+](=O)[O-]

RRx-001（Cat No.:I005506）is an investigational small molecule with potential therapeutic applications in cancer treatment. It functions as a novel immune-modulating agent, targeting various pathways to enhance the immune response against tumors. RRx-001 has been shown to inhibit the activity of immune checkpoint regulators and improve tumor blood flow, thereby promoting anti-tumor immunity. It is being explored in combination with other cancer therapies, such as chemotherapy and immunotherapy, to improve treatment outcomes. As a clinical trial drug, its safety, efficacy, and optimal use are still under evaluation in ongoing studies.